Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

AM2201

  • Zoom
    AM2201
  • AM2201
Cat No: 10707
Biochemicals - Analytical Standards
Cayman
Price is excluding VAT and does not include packaging neither shipping

AM2201 (Item No. 10707) is an analytical reference material characterized as a synthetic cannabinoid.{18696} AM2201 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

More

This article is not for sale online.
Contact us for more information about this article.

Territorial Availability: Available through Bertin Pharma only in Europe
Special Advice: regulated item by French and American Administrations DEA + ANSM / special delivery time and additional fees.
Synonyms:
  • [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone
Correlated keywords:
  • AM-2201 CB
Product Overview:
AM2201 (Item No. 10707) is an analytical reference material characterized as a synthetic cannabinoid.{18696} AM2201 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
Size 1 mg
Shipping dry ice
Stability Store at -20 degrees; shelf life 1095 days
CAS Number 335161-24-5
Molecular Formula C24H22FNO
SMILES O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CCCCCF)C4=CC=CC=C43
Molecular Weight 359,4
Formulation A neat solid
Purity ≥98%
Custom Code 3822.00
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : AM2201 There are 9 products.

Search